n6™ and SeqCenter Join Forces to Revolutionize Metagenomics Data Quality
In a significant development for the field of microbiome research, n6™ has announced a strategic partnership with SeqCenter aimed at delivering unparalleled data quality through a new full-length 16S sequencing service, as showcased during the FEMS Micro conference. This collaboration marks a significant step forward in the field of metagenomics, tapping into n6's cutting-edge iconPCR™ technology to enhance the quality and reproducibility of research data.
The essence of this partnership lies in its commitment to providing advanced microbiome analysis and making it accessible for researchers across various domains. The introduction of SeqCenter’s full-length 16S sequencing service leverages pacific biosciences long-read technology, allowing for remarkable species- and strain-level taxonomic resolution, which starkly contrasts with traditional short-read methods. This shift aims to empower microbiome researchers, providing them with a more refined understanding of the microbial ecosystems they study.
One of the most compelling aspects of the iconPCR technology is its ability to dramatically reduce chimeric sequences and amplification bias. This translates to results that are more reflective of the genuine microbial landscape within every sample, an essential aspect of metagenomic studies which can often suffer from inaccuracies introduced during the sequencing process. Furthermore, studies have shown that libraries prepared with iconPCR retain a higher number of high-confidence reads and detect significantly more unique amplicon sequence variants (ASVs), leading to closer clustering in diversity analyses. This ensures that the results are not only robust but also reliable, which is a crucial criterion for scientific research.
Additionally, n6 and SeqCenter's collaboration simplifies the workflow significantly for researchers. With the introduction of an automated, streamlined process, researchers are required only to send their samples and await actionable insights. This reduction in hands-on time diminishes potential manual errors and allows researchers to focus more on interpreting their data rather than getting bogged down in technical intricacies.
Even more exciting is that the partnership extends beyond just full-length 16S sequencing. The innovative benefits of iconPCR's technology can have transformative effects on any next-generation sequencing (NGS) workflow where data quality is paramount. This includes applications across metagenomics, environmental studies, clinical testing, and industrial applications—making it a versatile tool for researchers from various fields.
During the FEMS Micro conference, attendees were invited to visit SeqCenter’s booth to gain deeper insights into this novel workflow and to learn about how n6 and SeqCenter are collaboratively establishing a new benchmark for data quality in microbiome research.
SeqCenter has positioned itself as a prominent player in the next-generation sequencing service market, focusing on various workflows, including microbial genomics and metagenomics. By prioritizing innovation and customer success, SeqCenter strives to provide comprehensive, actionable insights that benefit researchers globally.
Meanwhile, n6 continues to pave the way in genomics technology as a pioneering platform company, known for revolutionizing sample preparation with their iconPCR—the world's first real-time, per-well-controlled thermocycler. This commitment to enhancing research capabilities is at the heart of n6’s mission to empower researchers with the highest quality data and reproducible results across all NGS applications.
As a result of this groundbreaking partnership, the landscape of microbiome research is set to evolve, offering superior data clarity and quality that researchers need, ultimately facilitating advancements in this expanding field of study. The world of metagenomics is on the brink of transformation, driven by innovative collaborations like that of n6 and SeqCenter.
The essence of this partnership lies in its commitment to providing advanced microbiome analysis and making it accessible for researchers across various domains. The introduction of SeqCenter’s full-length 16S sequencing service leverages pacific biosciences long-read technology, allowing for remarkable species- and strain-level taxonomic resolution, which starkly contrasts with traditional short-read methods. This shift aims to empower microbiome researchers, providing them with a more refined understanding of the microbial ecosystems they study.
One of the most compelling aspects of the iconPCR technology is its ability to dramatically reduce chimeric sequences and amplification bias. This translates to results that are more reflective of the genuine microbial landscape within every sample, an essential aspect of metagenomic studies which can often suffer from inaccuracies introduced during the sequencing process. Furthermore, studies have shown that libraries prepared with iconPCR retain a higher number of high-confidence reads and detect significantly more unique amplicon sequence variants (ASVs), leading to closer clustering in diversity analyses. This ensures that the results are not only robust but also reliable, which is a crucial criterion for scientific research.
Additionally, n6 and SeqCenter's collaboration simplifies the workflow significantly for researchers. With the introduction of an automated, streamlined process, researchers are required only to send their samples and await actionable insights. This reduction in hands-on time diminishes potential manual errors and allows researchers to focus more on interpreting their data rather than getting bogged down in technical intricacies.
Even more exciting is that the partnership extends beyond just full-length 16S sequencing. The innovative benefits of iconPCR's technology can have transformative effects on any next-generation sequencing (NGS) workflow where data quality is paramount. This includes applications across metagenomics, environmental studies, clinical testing, and industrial applications—making it a versatile tool for researchers from various fields.
During the FEMS Micro conference, attendees were invited to visit SeqCenter’s booth to gain deeper insights into this novel workflow and to learn about how n6 and SeqCenter are collaboratively establishing a new benchmark for data quality in microbiome research.
SeqCenter has positioned itself as a prominent player in the next-generation sequencing service market, focusing on various workflows, including microbial genomics and metagenomics. By prioritizing innovation and customer success, SeqCenter strives to provide comprehensive, actionable insights that benefit researchers globally.
Meanwhile, n6 continues to pave the way in genomics technology as a pioneering platform company, known for revolutionizing sample preparation with their iconPCR—the world's first real-time, per-well-controlled thermocycler. This commitment to enhancing research capabilities is at the heart of n6’s mission to empower researchers with the highest quality data and reproducible results across all NGS applications.
As a result of this groundbreaking partnership, the landscape of microbiome research is set to evolve, offering superior data clarity and quality that researchers need, ultimately facilitating advancements in this expanding field of study. The world of metagenomics is on the brink of transformation, driven by innovative collaborations like that of n6 and SeqCenter.
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.